Walbert Keli bought SPRB
December 11, 2025 · Form 4 insider transaction
Walbert Keli bought 3,400 shares of Spruce Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,400
Price
$0.00
Total value
N/A
InsiderWalbert Keli
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 11, 2025
Filing dateDecember 15, 2025
Shares owned after3,400
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the 2020 Equity Incentive Plan (the "Plan") through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan).